(0) Rising cases of cancer such as breast and lung cancer is prompting key players to develop highly developed and precise test furthering expansion prospects DUBAI, UAE / ACCESSWIRE / April 6, 2021 / ESOMAR-certified research intelligence firm, Future Market Insights' recent study on cancer tissue diagnostics market presents a healthy growth outlook through 2021. According to the report, the market was valued at US$ 4345 Mn. It is driven by the increasing investment in cancer research activities to discover high precision biomarkers. Against this backdrop, the rising cases of cancers have been fuelling the demand for cancer tissue diagnostic. The market is forecast to exhibit a CAGR of nearly 8.5% through 2031.